Meeting of the National Vaccine Advisory Committee Vaccine Safety Working Group, 8543 [E9-3977]

Download as PDF Federal Register / Vol. 74, No. 36 / Wednesday, February 25, 2009 / Notices although it recognized that the government still may prohibit untruthful or misleading advertising or impose other measures to ensure that ads are not deceptive.2 In subsequent cases, courts, including the Supreme Court, have held that a commercial advertisement does not necessarily enjoy full First Amendment protection just because it promotes a fully protected product or activity or incorporates statements that, outside the advertising context, are fully protected. See, e.g., Zauderer v. Office of Disciplinary Counsel of the Supreme Court of Ohio, 471 U.S. 626, 637 & n.7 (1985) (holding that statements contained in an advertisement for legal services regarding the legal rights of persons injured by the Dalkon shield normally would be fully protected speech, but not when presented in the context of an advertisement that proposed a commercial transaction—the offer of legal representation).3 The Commission has determined that the MID is unnecessary in light of the Supreme Court’s commercial speech jurisprudence developed since the MID’s adoption. The Court’s commercial speech cases, not the MID, delimit the constitutional constraints on challenges to deceptive advertising claims for books and other publications that are commercially marketed. For the reasons described, the Commission hereby rescinds its ‘‘Advertising in Books’’ enforcement policy. List of Subjects: Advertising, Consumer protection, Trade practices. Authority: 15 U.S.C. 41-58 By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. E9–3940 Filed 2–24–09: 8:45 am] pwalker on PROD1PC71 with NOTICES BILLING CODE 6750–01–S although meriting some protection, is of less constitutional moment than other forms of speech.’’). 2 425 U.S. at 771-72 & n.24. Accord Bates v. State Bar of Arizona, 433 U.S. 350, 382 (1977) (holding that advertising for legal services is commercial speech and noting that false, deceptive, or misleading advertising of legal services can be prohibited). 3 Cf. Rushman v. City of Milwaukee, 959 F. Supp. 1040, 1043-44 (E.D. Wis. 1997) (holding that the city could not regulate speech of an astrologer, because the targeted speech did not involve the proposal of a commercial transaction: ‘‘[A]n astrologer’s advice neither proposes nor encourages an additional transaction. In contrast, if [the astrologer] told her clients that they had curses and she could remove them, that would be commercial speech because she would be using astrology to sell her curse-lifting services.’’). VerDate Nov<24>2008 18:09 Feb 24, 2009 Jkt 217001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee Vaccine Safety Working Group AGENCY: Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice of meeting. SUMMARY: The Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) Vaccine Safety Working Group will hold a meeting. The meeting is open to the public. Pre-registration is required for both public attendance and comment. The event will be webcast live and audio conferencing will be available. DATES: The meeting will be held on March 16, 2009, from 9 a.m. to 5 p.m. ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Ms. Kirsten Vannice, National Vaccine Program Office, Department of Health and Human Services, Room 443–H, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201. Phone: (202) 690–5566; Fax: (202) 260–1165; e-mail: kirsten.vannice@hhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. Section 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The National Vaccine Advisory Committee was established to provide advice and make recommendations to the Director of the National Vaccine Program, on matters related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. The NVAC Vaccine Safety Working Group was initially established to (1) undertake and coordinate a scientific review of the draft Centers for Disease Control and Prevention (CDC) Immunization Safety Office (ISO) Scientific Agenda, and (2) review the current vaccine safety system. On March 16, 2009, the NVAC Vaccine Safety Working Group will meet to hear comments from stakeholders on the ISO Scientific Agenda. Stakeholder participants will PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 8543 be asked to comment broadly on two areas: (1) The content of the draft ISO research agenda and (2) approaches for developing priorities for the draft ISO research agenda. Organizations and individuals with a strong interest in vaccine safety are encouraged to attend. Additional guidance and materials will be provided in advance to registered participants. The information collected during this meeting will inform the Working Group on issues and concerns that should be taken into consideration in developing recommendations to be made to NVAC on the ISO scientific agenda. Public attendance at the meeting is limited to space available and interested individuals are encouraged to register early to secure a space. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the contact person above at least one week prior to the meeting. Members of the public will have the opportunity to provide comments at the meeting. Public comment will be limited to five minutes per speaker. Pre-registration is required for both public attendance and comment. Any members of the public who wish to have printed material distributed to NVAC Vaccine Safety Working Group members should submit materials to the Executive Secretary, NVAC, through the contact person listed above prior to close of business March 9, 2009. Audio-conferencing will be available. Call in numbers, a draft agenda, a link to the webcast, and additional materials will be posted on the NVAC Vaccine Safety Working Group Web site (https://www.hhs.gov/ nvpo/nvac/vaccinesafety.html) prior to the meeting. Dated: February 19, 2009. Raymond A. Strikas, Medical Officer, National Vaccine Program Office, U.S. Department of Health and Human Services. [FR Doc. E9–3977 Filed 2–24–09; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Statement of Delegation of Authority Notice is hereby given that I have delegated to the Director, Agency for Healthcare Research and Quality (AHRQ), the authorities vested in the Secretary of the Department of Health and Human Services under Section 204, E:\FR\FM\25FEN1.SGM 25FEN1

Agencies

[Federal Register Volume 74, Number 36 (Wednesday, February 25, 2009)]
[Notices]
[Page 8543]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-3977]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee Vaccine Safety 
Working Group

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of Public Health and Science.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) is hereby 
giving notice that the National Vaccine Advisory Committee (NVAC) 
Vaccine Safety Working Group will hold a meeting. The meeting is open 
to the public. Pre-registration is required for both public attendance 
and comment. The event will be webcast live and audio conferencing will 
be available.

DATES: The meeting will be held on March 16, 2009, from 9 a.m. to 5 
p.m.

ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey 
Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Ms. Kirsten Vannice, National Vaccine 
Program Office, Department of Health and Human Services, Room 443-H, 
Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, 
DC 20201. Phone: (202) 690-5566; Fax: (202) 260-1165; e-mail: 
kirsten.vannice@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. Section 300aa-1), the Secretary of Health 
and Human Services was mandated to establish the National Vaccine 
Program to achieve optimal prevention of human infectious diseases 
through immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The National Vaccine Advisory Committee was 
established to provide advice and make recommendations to the Director 
of the National Vaccine Program, on matters related to the Program's 
responsibilities. The Assistant Secretary for Health serves as Director 
of the National Vaccine Program.
    The NVAC Vaccine Safety Working Group was initially established to 
(1) undertake and coordinate a scientific review of the draft Centers 
for Disease Control and Prevention (CDC) Immunization Safety Office 
(ISO) Scientific Agenda, and (2) review the current vaccine safety 
system.
    On March 16, 2009, the NVAC Vaccine Safety Working Group will meet 
to hear comments from stakeholders on the ISO Scientific Agenda. 
Stakeholder participants will be asked to comment broadly on two areas: 
(1) The content of the draft ISO research agenda and (2) approaches for 
developing priorities for the draft ISO research agenda. Organizations 
and individuals with a strong interest in vaccine safety are encouraged 
to attend. Additional guidance and materials will be provided in 
advance to registered participants. The information collected during 
this meeting will inform the Working Group on issues and concerns that 
should be taken into consideration in developing recommendations to be 
made to NVAC on the ISO scientific agenda.
    Public attendance at the meeting is limited to space available and 
interested individuals are encouraged to register early to secure a 
space. Individuals who plan to attend and need special assistance, such 
as sign language interpretation or other reasonable accommodations, 
should notify the contact person above at least one week prior to the 
meeting. Members of the public will have the opportunity to provide 
comments at the meeting. Public comment will be limited to five minutes 
per speaker. Pre-registration is required for both public attendance 
and comment. Any members of the public who wish to have printed 
material distributed to NVAC Vaccine Safety Working Group members 
should submit materials to the Executive Secretary, NVAC, through the 
contact person listed above prior to close of business March 9, 2009. 
Audio-conferencing will be available. Call in numbers, a draft agenda, 
a link to the webcast, and additional materials will be posted on the 
NVAC Vaccine Safety Working Group Web site (https://www.hhs.gov/nvpo/
nvac/vaccinesafety.html) prior to the meeting.

    Dated: February 19, 2009.
Raymond A. Strikas,
Medical Officer, National Vaccine Program Office, U.S. Department of 
Health and Human Services.
[FR Doc. E9-3977 Filed 2-24-09; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.